Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors

Frontiers in Physiology

Volumn 4 JAN, Issue , 2014, Pages

  Sedlakova, Olga ^a   Svastova, Eliska ^a   Takacova, Martina ^a   Kopacek, Juraj ^a   Pastorek, Jaromir ^a   Pastorekova, Silvia ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Carbonic anhydrase IX; Hypoxia; PH regulation; Tumor microenvironment

Indexed keywords

EID: 84893522300     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00400     Document Type: Review

References (175)

1. Alper, S. L. (2006). Molecular physiology of SLC4 anion exchangers. Exp. Physiol. 91, 153-161. doi: 10.1113/expphysiol.2005.031765.
2. Axelson, H., Fredlund, E., Ovenberger, M., Landberg, G., and Påhlman, S. (2005). Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin. Cell Dev. Biol. 16, 554-563. doi: 10.1016/j.semcdb.2005.03.007.
3. Barathova, M., Takacova, M., Holotnakova, T., Gibadulinova, A., Ohradanova, A., Zatovicova, M., et al. (2008). Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype. Br. J. Cancer 98, 129-136. doi: 10.1038/sj.bjc.6604111.
4. Bartosova, M., Parkkila, S., Pohlodek, K., Karttunen, T. J., Galbavy, S., Mucha, V., et al. (2002). Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J. Pathol. 197, 314-321. doi: 10.1002/path.1120.
5. Baumgartner, W., Osmanagic, A., Gebhard, M., Kraemer, S., and Golenhofen, N. (2013). Different pH-dependencies of the two synaptic adhesion molecules N-cadherin and cadherin-11 and the possible functional implication for long-term potentiation. Synapse 67, 705-715. doi: 10.1002/syn.21679.
6. Beasley, N. J., Wykoff, C. C., Watson, P. H., Leek, R., Turley, H., Gatter, K., et al. (2001). Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 61, 5262-5267.
7. Boedtkjer, E., Moreira, J. M., Mele, M., Vahl, P., Wielenga, V. T., Christiansen, P. M., et al. (2013). Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7). Int. J. Cancer 132, 1288-1299. doi: 10.1002/ijc.27782.
8. Boron, W. F., Chen, L., and Parker, M. D. (2009). Modular structure of sodium-coupled bicarbonate transporters. J. Exp. Biol. 212, 1697-1706. doi: 10.1242/jeb.028563.
9. Bosco, M. C., and Varesio, L. (2012). Dendritic cell reprogramming by the hypoxic environment. Immunobiology 217, 1241-1249. doi: 10.1016/j.imbio.2012.07.023.
10. Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S., Clough, R. W., Dewhirst, M. W., et al. (2001). Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51, 349-353. doi: 10.1016/S0360-3016(01)01630-3.
11. Brockton, N., Dort, J., Lau, H., Hao, D., Brar, S., Klimowicz, A., et al. (2011). High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 80, 249-257. doi: 10.1016/j.ijrobp.2010.11.059.
12. Brockton, N. T., Klimowicz, A. C., Bose, P., Petrillo, S. K., Konno, M., Rudmik, L., et al. (2012). High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma. Oral Oncol. 48, 615-622. doi: 10.1016/j.oraloncology.2012.01.018.
13. Bui, M. H., Seligson, D., Han, K. R., Pantuck, A. J., Dorey, F. J., Huang, Y., et al. (2003). Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin. Cancer Res. 9, 802-811.
14. Cardone, R. A., Bagordam, A., Bellizzi, A., Busco, G., Guerra, L., Paradiso, A., et al. (2005). Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol. Biol. Cell 16, 3117-3127. doi: 10.1091/mbc.E04-10-0945.
15. Cardone, R. A., Bellizzi, A., Busco, G., Weinman, E. J., Dell'Aquila, M. E., Casavola, V., et al. (2007). The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol. Biol. Cell 18, 1768-1780. doi: 10.1091/mbc.E06-07-0617.
16. Casey, J. R. (2006). Why bicarbonate? Biochem. Cell Biol. 84, 930-939. doi: 10.1139/o06-184.
17. Chen, C. L., Chu, J. S., Su, W. C., Huang, S. C., and Lee, W. Y. (2010). Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch. 457, 53-61. doi: 10.1007/s00428-010-0938-0.
18. Chen, J., Röcken, C., Hoffmann, J., Krüger, S., Lendeckel, U., Rocco, A., et al. (2005). Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut 54, 920-927. doi: 10.1136/gut.2004.047340.
19. Chen, J. L., Lucas, J. E., Schroeder, T., Mori, S., Wu, J., Nevins, J., et al. (2008). The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet. 4:e1000293. doi: 10.1371/journal.pgen.1000293.
20. Chiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., et al. (2009). Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69, 358-368. doi: 10.1158/0008-5472.CAN-08-2470.
21. Chitneni, S. K., Palmer, G. M., Zalutsky, M. R., and Dewhirst, M. W. (2011). Molecular imaging of hypoxia. J. Nucl. Med. 52, 165-168. doi: 10.2967/jnumed.110.075663.
22. Cleven, A. H., van Engeland, M., Wouters, B. G., and de Bruïne, A. P. (2007). Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cell. Oncol. 29, 229-240.
23. Couvelard, A., O'Toole, D., Turley, H., Leek, R., Sauvanet, A., Degott, C., et al. (2005a). Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br. J. Cancer 92, 94-101. doi: 10.1038/sj.bjc.6602245.
24. Couvelard, A., O'Toole, D., Leek, R., Turley, H., Sauvanet, A., Degott, C., et al. (2005b). Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology 46, 668-676. doi: 10.1111/j.1365-2559.2005.02160.x.
25. Csaderova, L., Debreova, M., Radvak, P., Stano, M., Vrestiakova, M., Kopacek, J., et al. (2013). The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration. Front. Physiol. 4:271. doi: 10.3389/fphys.2013.00271.
26. Currie, M. J., Beardsley, B. E., Harris, G. C., Gunningham, S. P., Dachs, G. U., Dijkstra, B., et al. (2013). Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Hum. Pathol. 44, 402-411. doi: 10.1016/j.humpath.2012.06.004.
27. Dai, C., Sun, F., Zhu, C., and Hu, X. (2013). Tumor environmental factors glucose deprivation and lactic acidosis induce mitotic chromosomal instability-an implication in aneuploid human tumors. PLoS ONE 8:e63054. doi: 10.1371/journal.pone.0063054.
28. Daniel, C., Bell, C., Burton, C., Harguindey, S., Reshkin, S. J., and Rauch, C. (2013). The role of proton dynamics in the development and maintenance of multidrug resistance in cancer. Biochim. Biophys. Acta 1832, 606-617. doi: 10.1016/j.bbadis.2013.01.020.
29. Deschamps, L., Bacha, D., Rebours, V., Mebarki, M., Bretagnol, F., Panis, Y., et al. (2012). The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum. Neuroendocrinology 95, 214-222. doi: 10.1159/000329873.
30. De Schutter, H., Barbé, B., Spaepen, M., Begg, A. C., Balm, A., Gregoire, V., et al. (2006). Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1. Radiother. Oncol. 80, 143-150. doi: 10.1016/j.radonc.2006.07.018.
31. Dhup, S., Dadhich, R. K., Porporato, P. E., and Sonveaux, P. (2012). Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr. Pharm. Des. 18, 1319-1330. doi: 10.2174/138161212799504902.
32. Ditte, P., Dequiedt, F., Svastova, E., Hulikova, A., Ohradanova-Repic, A., Zatovicova, M., et al. (2011). Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors. Cancer Res. 71, 7558-7567. doi: 10.1158/0008-5472.CAN-11-2520.
33. Dorai, T., Sawczuk, I. S., Pastorek, J., Wiernik, P. H., and Dutcher, J. P. (2005). The role of carbonic anhydrase IX overexpression in kidney cancer. Eur. J. Cancer 41, 2935-2947. doi: 10.1016/j.ejca.2005.09.011.
34. Dubois, L., Peeters, S., Lieuwes, N. G., Geusens, N., Thiry, A., Wigfield, S., et al. (2011). Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother. Oncol. 99, 424-431. doi: 10.1016/j.radonc.2011.05.045.
35. Dubois, L., Peeters, S. G., van Kuijk, S. J., Yaromina, A., Lieuwes, N. G., Saraya, R., et al. (2013). Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother. Oncol. 108, 523-528. doi: 10.1016/j.radonc.2013.06.018.
36. Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., et al. (2013). Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 73, 1524-1535. doi: 10.1158/0008-5472.CAN-12-2796.
37. Fang, J. S., Gillies, R. D., and Gatenby, R. A. (2008). Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin. Cancer Biol. 18, 330-337. doi: 10.1016/j.semcancer.2008.03.011.
38. Fiaschi, T., Giannoni, E., Taddei, M. L., Cirri, P., Marini, A., Pintus, G., et al. (2013). Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle 12, 1791-1801. doi: 10.4161/cc.24902.
39. Fischer, B., Müller, B., Fischer, K. G., Baur, N., and Kreutz, W. (2000a). Acidic pH inhibits non-MHC-restricted killer cell functions. Clin. Immunol. 96, 252-263. doi: 10.1006/clim.2000.4904.
40. Fischer, B., Müller, B., Fisch, P., and Kreutz, W. (2000b). An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J. Immunother. 23, 196-207. doi: 10.1097/00002371-200003000-00004.
41. Fujiwara, D., Kato, K., Nohara, S., Iwanuma, Y., and Kajiyama, Y. (2013). The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines. Biochem. Biophys. Res. Commun. 434, 773-778. doi: 10.1016/j.bbrc.2013.04.008.
42. Gatenby, R. A., and Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 8, 56-61. doi: 10.1038/nrc2255.
43. Gerweck, L. E., and Seetharaman, K. (1996). Cellular pH gradient in tumor vs. normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56, 1194-1198.
44. Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Pastorek, J., Wykoff, C. C., Gatter, K. C., et al. (2001). Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 61, 7992-7998.
45. Gieling, R. G., Babur, M., Mamnani, L., Burrows, N., Telfer, B. A., Carta, F., et al. (2012). Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J. Med. Chem. 55, 5591-5600. doi: 10.1021/jm300529u.
46. Gillies, R. J., Verduzco, D., and Gatenby, R. A. (2012). Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat. Rev. Cancer 12, 487-493. doi: 10.1038/nrc3298.
47. Gonzalez-Begne, M., Nakamoto, T., Nguyen, H. V., Stewart, A. K., Alper, S. L., and Melvin, J. E. (2007). Enhanced formation of a HCO3-transport metabolon in exocrine cells of Nhe1-/-mice. J. Biol. Chem. 282, 35125-35132. doi: 10.1074/jbc.M707266200.
48. Guedj, N., Bretagnol, F., Rautou, P. E., Deschamps, L., Cazals-Hatem, D., Bedossa, P., et al. (2011). Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas. Hum. Pathol. 42, 1702-1709. doi: 10.1016/j.humpath.2011.01.015.
49. Haapasalo, J., Hilvo, M., Nordfors, K., Haapasalo, H., Parkkila, S., Hyrskyluoto, A., et al. (2008). Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas. Neuro Oncol. 10, 131-138. doi: 10.1215/15228517-2007-065.
50. Halestrap, A. P. (2013). The SLC16 gene family-structure, role and regulation in health and disease. Mol. Aspects Med. 34, 337-349. doi: 10.1016/j.mam.2012.05.003.
51. Harguindey, S., Arranz, J. L., Polo Orozco, J. D., Rauch, C., Fais, S., Cardone, R. A., et al. (2013). Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs-an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research. J. Transl. Med. 11, 282. doi: 10.1186/1479-5876-11-282.
52. Harris, A. L. (2002). Hypoxia-a key regulatory factor in tumor growth. Nat. Rev. Cancer 2, 38-47. doi: 10.1038/nrc704.
53. Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., and Jain, R. K. (2002). Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin. Cancer Res. 8, 1284-1291.
54. Helmlinger, G., Yuan, F., Dellian, M., and Jain, R. K. (1997). Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177-182.
55. Hjelmeland, A. B., Wu, Q., Heddleston, J. M., Choudhary, G. S., MacSwords, J., Lathia, J. D., et al. (2011). Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ. 18, 829-840. doi: 10.1038/cdd.2010.150.
56. Holotnakova, T., Tylkova, L., Takacova, M., Kopacek, J., Petrik, J., Pastorekova, S., et al. (2010). Role of the HBx oncoprotein in carbonic anhydrase 9 induction. J. Med. Virol. 82, 32-40. doi: 10.1002/jmv.21671.
57. Hui, E. P., Chan, A. T., Pezzella, F., Turley, H., To, K. F., Poon, T. C., et al. (2002). Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin. Cancer Res. 8, 2595-2604.
58. Hulikova, A., Harris, A. L., Vaughan-Jones, R. D., and Swietach, P. (2012). Acid-extrusion from tissue: the interplay between membrane transporters and pH buffers. Curr. Pharm. Des. 18, 1331-1337. doi: 10.2174/138161212799504920.
59. Hulikova, A., Harris, A. L., Vaughan-Jones, R. D., and Swietach, P. (2013). Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia. J. Cell. Physiol. 228, 743-752. doi: 10.1002/jcp.24221.
60. Hyrsl, L., Zavada, J., Zavadova, Z., Kawaciuk, I., Vesely, S., and Skapa, P. (2009). Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract. Neoplasma 56, 298-302. doi: 10.4149/neo_2009_04_29.
61. Ihnatko, R., Kubes, M., Takacova, M., Sedlakova, O., Sedlak, J., Pastorek, J., et al. (2006). Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia. Int. J. Oncol. 29, 1025-1033.
62. Ilie, M., Mazure, N. M., Hofman, V., Ammadi, R. E., Ortholan, C., Bonnetaud, C., et al. (2010). High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br. J. Cancer 102, 1627-1635. doi: 10.1038/sj.bjc.6605690.
63. Innocenti, A., Pastorekova, S., Pastorek, J., Scozzafava, A., De Simone, G., and Supuran, C. T. (2009). The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as an intrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors. Bioorg. Med. Chem. Lett. 19, 5825-5828. doi: 10.1016/j.bmcl.2009.08.088.
64. Innocenti, A., Vullo, D., Scozzafava, A., Casey, J. R., and Supuran, C. (2005). Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg. Med. Chem. Lett. 15, 573-578. doi: 10.1016/j.bmcl.2004.11.057.
65. Ivanov, S. V., Kuzmin, I., Wei, M. H., Pack, S., Geil, L., Johnson, B. E., et al. (1998). Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. U.S.A. 95, 12596-12601. doi: 10.1073/pnas.95.21.12596.
66. Joffre, C., Barrow, R., Ménard, L., Calleja, V., Hart, I. R., and Kermorgant, S. (2011). A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 13, 827-837. doi: 10.1038/ncb2257.
67. Kaelin, W. G. Jr., and Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402. doi: 10.1016/j.molcel.2008.04.009.
68. Kaluz, S., Kaluzova, M., Chrastina, A., Olive, P. L., Pastorekova, S., Pastorek, J., et al. (2002). Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Res. 62, 4469-4477.
69. Kennedy, K. M., and Dewhirst, M. W. (2010). Tumor metabolism of lactate: the influence and therapeutic potential for MTC and CD147 regulation. Future Oncol. 6, 127. doi: 10.2217/fon.09.145.
70. Kim, S., Jung, W. H., and Koo, J. S. (2013). The expression of Glut-1, CAIX, and MCT4 in mucinous carcinoma. J. Breast Cancer 16, 146-151. doi: 10.4048/jbc.2013.16.2.146.
71. Kivelä, A., Parkkila, S., Saarnio, J., Karttunen, T. J., Kivelä, J., Parkkila, A. K., et al. (2000). Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am. J. Pathol. 156, 577-584. doi: 10.1016/S0002-9440(10)64762-1.
72. Kon-no, H., Ishii, G., Nagai, K., Yoshida, J., Nishimura, M., Nara, M., et al. (2006). Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer 54, 409-418. doi: 10.1016/j.lungcan.2006.08.017.
73. Kopacek, J., Barathova, M., Dequiedt, F., Sepelakova, J., Kettmann, R., Pastorek, J., et al. (2005). MAPK pathway contributes to density-and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Biochim. Biophys. Acta 1729, 41-49. doi: 10.1016/j.bbaexp.2005.03.003.
74. Korhonen, K., Parkkila, A. K., Helen, P., Välimäki, R., Pastorekova, S., Pastorek, J., et al. (2009). Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features. J. Neurosurg. 111, 472-477. doi: 10.3171/2008.10.17672.
75. Korkeila, E., Talvinen, K., Jaakkola, P. M., Minn, H., Syrjänen, K., Sundström, J., et al. (2009). Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br. J. Cancer 100, 874-880. doi: 10.1038/sj.bjc.6604949.
76. Koukourakis, M. I., Giatromanolaki, A., Danielidis, V., and Sivridis, E. (2008). Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Int. J. Radiat. Biol. 84, 47-52. doi: 10.1080/09553000701616114.
77. Koukourakis, M. I., Pitiakoudis, M., Giatromanolaki, A., Tsarouha, A., Polychronidis, A., Sivridis, E., et al. (2006a). Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci. 97, 1056-1060. doi: 10.1111/j.1349-7006.2006.00298.x.
78. Koukourakis, M. I., Bentzen, S. M., Giatromanolaki, A., Wilson, G. D., Daley, F. M., Saunders, M. I., et al. (2006b). Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J. Clin. Oncol. 24, 727-735. doi: 10.1200/JCO.2005.02.7474.
79. Kwon, J. E., Jung, W. H., and Koo, J. S. (2013). The expression of metabolism-related proteins in phyllodes tumors. Tumour Biol. 34, 115-124. doi: 10.1007/s13277-012-0518-9.
80. Lauritzen, G., Jensen, M. B., Boedtkjer, E., Dybboe, R., Aalkjaer, C., Nylandsted, J., et al. (2010). NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. Exp. Cell Res. 316, 2538-2553. doi: 10.1016/j.yexcr.2010.06.005.
81. Lee, A. H., and Tannock, I. F. (1998). Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Res. 58, 1901-1908.
82. Lendahl, U., Lee, K. L., Yang, H., and Poellinger, L. (2009). Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10, 821-832. doi: 10.1038/nrg2665.
83. Levine, A. J., and Puzio-Kuter, A. M. (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340-1344. doi: 10.1126/science.1193494.
84. Lin, A., and Hahn, S. M. (2012). Hypoxia imaging markers and applications for radiation treatment planning. Semin. Nucl. Med. 42, 343-352. doi: 10.1053/j.semnuclmed.2012.04.002.
85. Lock, F. E., McDonald, P. C., Lou, Y., Serrano, I., Chafe, S. C., Ostlund, C., et al. (2013). Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene 32, 5210-5219. doi: 10.1038/onc.2012.550.
86. Lou, Y., McDonald, P. C., Oloumi, A., Chia, S., Ostlund, C., Ahmadi, A., et al. (2011). Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res. 71, 3364-3376. doi: 10.1158/0008-5472.CAN-10-4261.
87. Ludwig, F. T., Schwab, A., and Stock, C. (2013). The Na+ /H+-exchanger (NHE1) generates pH nanodomains at focal adhesions. J. Cell. Physiol. 228, 1351-1358. doi: 10.1002/jcp.24293.
88. Marino, M. L., Pellegrini, P., Di Lernia, G., Djavaheri-Mergny, M., Brnjic, S., Zhang, X., et al. (2012). Autophagy is a protective mechanism for human melanoma cells under acidic stress. J. Biol. Chem. 287, 30664-30676. doi: 10.1074/jbc.M112.339127.
89. Martin, C., Pedersen, S. F., Schwab, A., and Stock, C. (2011). Intracellular pH gradients in migrating cells. Am. J. Physiol. Cell Physiol. 300, C490-C495. doi: 10.1152/ajpcell.00280.2010.
90. Martínez-Zaguilán, R., Seftor, E. A., Seftor, R. E., Chu, Y. W., Gillies, R. J., and Hendrix, M. J. (1996). Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 14, 176-186.
91. Matsubara, T., Diresta, G. R., Kakunaga, S., Li, D., and Healey, J. H. (2013). Additive influence of extracellular pH, oxygen tension, and pressure on invasiveness and survival of human osteosarcoma cells. Front. Oncol. 3:199. doi: 10.3389/fonc.2013.00199.
92. McIntyre, A., Patiar, S., Wigfield, S., Li, J. L., Ledaki, I., Turley, H., et al. (2012). Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy. Clin. Cancer Res. 18, 3100-3111. doi: 10.1158/1078-0432.CCR-11-1877.
93. Mekhail, K., Gunaratnam, L., Bonicalzi, M. E., and Lee, S. (2004). HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 6, 642-647. doi: 10.1038/ncb1144.
94. Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M., Gottfried, E., and Noessner, E. (2012). Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation. Int. J. Cancer 131, 633-640. doi: 10.1002/ijc.26410.
95. Moellering, R. E., Black, K. C., Krishnamurty, C., Baggett, B. K., Stafford, P., Rain, M., et al. (2008). Acid treatment of melanoma cells selects for invasive phenotypes. Clin. Exp. Metastasis 25, 411-425. doi: 10.1007/s10585-008-9145-7.
96. Morgan, P. E., Pastorekova, S., Stuart-Tilley, A. K., Alper, S. L., and Casey, J. R. (2007). Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. Am. J. Physiol. Cell Physiol. 293, C738-748. doi: 10.1152/ajpcell.00157.2007.
97. Newell, K., Franchi, A., Pouyssegur, J., and Tannock, I. (1993). Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc. Natl. Acad. Sci. U.S.A. 90, 1127-1131. doi: 10.1073/pnas.90.3.1127.
98. Odunewu, A., and Fliegel, L. (2013). Acidosis-mediated regulation of the NHE1 isoform of the Na+/H+ exchanger in renal cells. Am. J. Physiol. Renal Physiol. 305, F370-F381. doi: 10.1152/ajprenal.00598.2012.
99. Oosterwijk-Wakka, J. C., Boerman, O. C., Mulders, P. F., and Oosterwijk, E. (2013). Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma. Int. J. Mol. Sci. 14, 11402-11423. doi: 10.3390/ijms140611402.
100. Opavskỳ, R., Pastorekova, S., Zelník, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., et al. (1996). Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 33, 480-487. doi: 10.1006/geno.1996.0223.
101. Orlowski, A., De Giusti, V. C., Morgan, P. E., Aiello, E. A., and Alvarez, B. V. (2012). Binding of carbonic anhydrase IX to extracellular loop 4 of the NBCe1 Na+/HCO3-cotransporter enhances NBCe1-mediated HCO3-influx in the rat heart. Am. J. Physiol. Cell Physiol. 303, C69-C80. doi: 10.1152/ajpcell.00431.2011.
102. Parkkila, S., Lasota, J., Fletcher, J. A., Ou, W. B., Kivelä, A. J., Nuorva, K., et al. (2010). Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors. Mod. Pathol. 23, 743-750. doi: 10.1038/modpathol.2009.189.
103. Parkkila, S., Parkkila, A. K., Saarnio, J., Kivelä, J., Karttunen, T. J., Kaunisto, K., et al. (2000). Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J. Histochem. Cytochem. 48, 1601-1608. doi: 10.1177/002215540004801203.
104. Parks, S. K., Chiche, J., and Pouyssegur, J. (2011). pH control mechanisms of tumor survival and growth. J. Cell. Physiol. 226, 299-308. doi: 10.1002/jcp.22400.
105. Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., et al. (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284, 34211-34222. doi: 10.1074/jbc.M109.041152.
106. Pastorek, J., and Pastorekova, S. (2010). "Molecular mechanisms regulating expression and function of cancer-associated anhydrase IX," in The Tumor Microenvironment, ed R. Bagley (New York, NY: Springer; Humana Press), 59-90.
107. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., et al. (1994). Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9, 2877-2888.
108. Pastorekova, S., Parkkila, S., Pastorek, J., and Supuran, C. T. (2004). Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. 19, 199-229. doi: 10.1080/14756360410001689540.
109. Pastorekova, S., Ratcliffe, P. J., and Pastorek, J. (2008). Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int. 101(Suppl. 4), 8-15. doi: 10.1111/j.1464-410X.2008.07642.x.
110. + exchanger NHE1 in stress-induced signal transduction: implications for cell proliferation and cell death. Pflugers Arch. 452, 249-59. doi: 10.1007/s00424-006-0044-y.
111. Peppicelli, S., Bianchini, F., Contena, C., Tombaccini, D., and Calorini, L. (2013). Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells. Clin. Exp. Metastasis 30, 957-967. doi: 10.1007/s10585-013-9595-4.
112. Pouysségur, J., Dayan, F., and Mazure, N. M. (2006). Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441, 437-443. doi: 10.1038/nature04871.
113. + exchanger NHE1. BMC Genomics 5:46. doi: 10.1186/1471-2164-5-46.
114. Rademakers, S. E., Lok, J., van der Kogel, A. J., Bussink, J., and Kaanders, J. H. (2011). Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1a, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer 11:167. doi: 10.1186/1471-2407-11-167.
115. Radvak, P., Repic, M., Svastova, E., Takacova, M., Csaderova, L., Strnad, H., et al. (2013). Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells. Oncol. Rep. 29, 1147-1153. doi: 10.3892/or.2013.2226.
116. Rafajova, M., Zatovicová, M., Kettmann, R., Pastorek, J., and Pastoreková, S. (2004). Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int. J. Oncol. 24, 995-1004.
117. Raghunand, N., Gatenby, R. A., and Gillies, R. J. (2003). Microenvironmental and cellular consequences of altered blood flow in tumours. Br. J. Radiol. 76, Spec. No 1, S11-S22. doi: 10.1259/bjr/12913493.
118. Rajaganeshan, R., Prasad, R., Guillou, P. J., Scott, N., Poston, G., and Jayne, D. G. (2009). Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases. Eur. J. Surg. Oncol. 35, 1286-1294. doi: 10.1016/j.ejso.2009.05.008.
119. Rajamäki, K., Nordström, T., Nurmi, K., Åkerman, K. E., Kovanen, P.T., Öörni, K., et al. (2013). Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome. J. Biol. Chem. 288, 13410-13419. doi: 10.1074/jbc.M112.426254.
120. Ratcliffe, P. J. (2013). Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J. Physiol. 591, 2027-2042. doi: 10.1113/jphysiol.2013.251470.
121. + exchanger, pH regulation and cancer. Recent Pat. Anticancer Drug Discov. 8, 85-99.
122. Riemann, A., Ihling, A., Schneider, B., Gekle, M., and Thews, O. (2013). Impact of extracellular acidosis on intracellular pH control and cell signaling in tumor cells. Adv. Exp. Med. Biol. 789, 221-228. doi: 10.1007/978-1-4614-7411-1_30.
123. Rofstad, E. K., Mathiesen, B., Kindem, K., and Galappathi, K. (2006). Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66, 6699-6707. doi: 10.1158/0008-5472.CAN-06-0983.
124. Sansone, P., Piazzi, G., Paterini, P., Strillacci, A., Ceccarelli, C., Minni, F., et al. (2009). Cyclooxygenase-2/carbonic anhydrase-IX up-regulation promotes invasive potential and hypoxia survival in colorectal cancer cells. J. Cell. Mol. Med. 13, 3876-3887. doi: 10.1111/j.1582-4934.2008.00580.x.
125. Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., et al. (2007a). IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117, 3988-4002. doi: 10.1172/JCI32533.
126. Sansone, P., Storci, G., Giovannini, C., Pandolfi, S., Pianetti, S., Taffurelli, M., et al. (2007b). p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells 25, 807-815. doi: 10.1634/stemcells.2006-0442.
127. Schulze, A., and Harris, A. L. (2012). How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364-373. doi: 10.1038/nature11706.
128. Schütze, D., Milde-Langosch, K., Witzel, I., Rody, A., Karn, T., Schmidt, M., et al. (2013). Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer. J. Cancer Res. Clin. Oncol. 139, 747-754. doi: 10.1007/s00432-013-1378-4.
129. Schwab, A., Fabian, A., Hanley, P. J., and Stock, C. (2012). Role of ion channels and transporters in cell migration. Physiol. Rev. 92, 1865-1913. doi: 10.1152/physrev.00018.2011.
130. Semenza, G. L. (2012). Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 33, 207-214. doi: 10.1016/j.tips.2012.01.005.
131. Sennoune, S. R., Luo, D., and Martinez-Zaguilan, R. (2004). Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem. Biophys. 40, 185-206. doi: 10.1385/CBB:40:2:185.
132. Shi, Q., Le, X., Wang, B., Abbruzzese, J. L., Xiong, Q., He, Y., et al. (2001). Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene 20, 3751-3756. doi: 10.1038/sj.onc.1204500.
133. Shimoda, L. A., Fallon, M., Pisarcik, S., Wang, J., and Semenza, G. L. (2006). HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L941-L949. doi: 10.1152/ajplung.00528.2005.
134. Shimokawa, N., Kumaki, I., Qiu, C. H., Ohmiya, Y., Takayama, K., and Koibuchi, N. (2005). Extracellular acidification enhances DNA binding activity of MafG-FosB heterodimer. J. Cell. Physiol. 205, 77-85. doi: 10.1002/jcp.20369.
135. Shin, H. J., Rho, S. B., Jung, D. C., Han, I. O., Oh, E. S., and Kim, J. Y. (2011). Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. J. Cell Sci. 124, 1077-1087. doi: 10.1242/jcs.072207.
136. Skrzypski, M., Jassem, E., Taron, M., Sanchez, J. J., Mendez, P., Rzyman, W., et al. (2008). Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin. Cancer Res. 14, 4794-4799. doi: 10.1158/1078-0432.CCR-08-0576.
137. Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., et al. (2008). Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930-3942. doi: 10.1172/JCI36843.
138. Sørensen, B. S., Alsner, J., Overgaard, J., and Horsman, M. R. (2007). Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. Radiother. Oncol. 83, 362-366. doi: 10.1016/j.radonc.2007.04.028.
139. Sorkin, A., and von Zastrow, M. (2009). Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609-622. doi: 10.1038/nrm2748.
140. Span, P. N., Bussink, J., Manders, P., Beex, L. V., and Sweep, C. G. (2003). Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Br. J. Cancer 89, 271-276. doi: 10.1038/sj.bjc.6601122.
141. Stillebroer, A. B., Mulders, P. F., Boerman, O. C., Oyen, W. J., and Oosterwijk, E. (2010). Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Eur. Urol. 58, 75-83. doi: 10.1016/j.eururo.2010.03.015.
142. Stock, C., and Schwab, A. (2009). Protons make tumor cells move like clockwork. Pflugers Arch. 458, 981-992. doi: 10.1007/s00424-009-0677-8.
143. Storci, G., Sansone, P., Trere, D., Tavolari, S., Taffurelli, M., Ceccarelli, C., et al. (2008). The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J. Pathol. 214, 25-37. doi: 10.1002/path.2254.
144. Stubbs, M., Rodrigues, L., Howe, F. A., Wang, J., Jeong, K. S., Veech, R., et al. (1994). Metabolic consequences of a reversed pH gradient in rat tumors. Cancer Res. 54, 4011-4016.
145. Svastova, E., Hulikova, A., Rafajova, M., Zatovicova, M., Gibadulinova, A., Casini, A., et al. (2004). Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 577, 439-445. doi: 10.1016/j.febslet.2004.10.043.
146. Svastova, E., and Pastorekova, S. (2013). Carbonic anhydrase IX: a hypoxia-controlled "catalyst" of cell migration. Cell Adh. Migr. 7, 226-231. doi: 10.4161/cam.23257.
147. Svastova, E., Witarski, W., Csaderova, L., Kosik, I., Skvarkova, L., Hulikova, A., et al. (2012). Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain. J. Biol. Chem. 287, 3392-3402. doi: 10.1074/jbc.M111.286062.
148. Svastova, E., Zilka, N., Zatovicova, M., Gibadulinova, A., Ciampor, F., Pastorek, J., et al. (2003). Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp. Cell Res. 290, 332-345. doi: 10.1016/S0014-4827(03)00351-3.
149. Swietach, P., Wigfield, S., Cobden, P., Supuran, C. T., Harris, A. L., and Vaughan-Jones, R. D. (2008). Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths. J. Biol. Chem. 283, 20473-20483. doi: 10.1074/jbc.M801330200.
150. Swinson, D. E., Jones, J. L., Cox, G., Richardson, D., Harris, A. L., and O'Byrne, K. J. (2004). Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int. J. Cancer 111, 43-50. doi: 10.1002/ijc.20052.
151. Takacova, M., Bartosova, M., Skvarkova, L., Zatovicova, M., Vidlickova, I., Csaderova, L., et al. (2013). Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma. Oncol. Lett. 5, 191-197. doi: 10.3892/ol.2012.1001.
152. Takacova, M., Holotnakova, T., Barathova, M., Pastorekova, S., Kopacek, J., and Pastorek, J. (2010). Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1. Oncol. Rep. 23, 869-874.
153. Tan, E. Y., Yan, M., Campo, L., Han, C., Takano, E., Turley, H., et al. (2009). The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br. J. Cancer 100, 405-411. doi: 10.1038/sj.bjc.6604844.
154. Thews, O., Dillenburg, W., Fellner, M., Buchholz, H. G., Bausbacher, N., Schreckenberger, M., et al. (2010). Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer. Eur. J. Nucl. Med. Mol. Imaging 37, 1935-1942. doi: 10.1007/s00259-010-1504-3.
155. Thews, O., Gassner, B., Kelleher, D. K., Schwerdt, G., and Gekle, M. (2006). Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8, 143-152. doi: 10.1593/neo.05697.
156. Tomes, L., Emberley, E., Niu, Y., Troup, S., Pastorek, J., Strange, K., et al. (2003). Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res. Treat. 81, 61-69. doi: 10.1023/A:1025476722493.
157. Torigoe, T., Izumi, H., Yoshida, Y., Ishiguchi, H., Okamoto, T., Itoh, H., et al. (2003). Low pH enhances Sp1 DNA binding activity and interaction with TBP. Nucleic Acids Res. 31, 4523-4530. doi: 10.1093/nar/gkg487.
158. Ullah, M. S., Davies, A. J., and Halestrap, A. P. (2006). The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 281, 9030-9037. doi: 10.1074/jbc.M511397200.
159. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. doi: 10.1126/science.1160809.
160. Walenta, S., and Mueller-Klieser, W. F. (2004). Lactate: mirror and motor of tumor malignancy. Semin. Radiat. Oncol. 14, 267-274. doi: 10.1016/j.semradonc.2004.04.004.
161. Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., et al. (2000). High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916-921.
162. Wang, Y., Wang, X. Y., Subjeck, J. R., and Kim, H. L. (2008). Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant. Mol. Cancer Ther. 7, 3867-3877. doi: 10.1158/1535-7163.MCT-08-0603.
163. Wiesener, M. S., Münchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., et al. (2001). Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res. 61, 5215-5222.
164. Willam, C., Warnecke, C., Schefold, J. C., Kügler, J., Koehne, P., Frei, U., et al. (2006). Inconsistent effects of acidosis on HIF-alpha protein and its target genes. Pflugers Arch. 451, 534-543. doi: 10.1007/s00424-005-1486-3.
165. Wilson, W. R., and Hay, M. P. (2011). Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393-410. doi: 10.1038/nrc3064.
166. Wind, T. C., Messenger, M. P., Thompson, D., Selby, P. J., and Banks, R. E. (2011). Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions. Ann. Clin. Biochem. 48, 112-120. doi: 10.1258/acb.2010.010240.
167. Wojtkowiak, J. W., Rothberg, J. M., Kumar, V., Schramm, K. J., Haller, E., Proemsey, J. B., et al. (2012). Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res. 72, 3938-3947. doi: 10.1158/0008-5472.CAN-11-3881.
168. Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., and Gillies, R. J. (2011). Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol. Pharm. 8, 2032-2038. doi: 10.1021/mp200292c.
169. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., et al. (2000). Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60, 7075-7083.
170. Yamagata, M., Hasuda, K., Stamato, T., and Tannock, I. F. (1998). The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br. J. Cancer 77, 1726-1731. doi: 10.1038/bjc.1998.289.
171. Zatovicova, M., Jelenska, L., Hulikova, A., Csaderova, L., Ditte, Z., Ditte, P., et al. (2010). Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr. Pharm. Des. 16, 3255-3263. doi: 10.2174/138161210793429832.
172. Zatovicova, M., and Pastorekova, S. (2013). Modulation of cell surface density of carbonic anhydrase IX by shedding of the ectodomain and endocytosis. Acta Virol. 57, 257-264. doi: 10.4149/av_2013_02_257.
173. Zatovicova, M., Sedlakova, O., Svastova, E., Ohradanova, A., Ciampor, F., Arribas, J., et al. (2005). Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17. Br. J. Cancer 93, 1267-1276. doi: 10.1038/sj.bjc.6602861.
174. Závada, J., Závadová, Z., Zatovicová, M., Hyrsl, L., and Kawaciuk, I. (2003). Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients. Br. J. Cancer 89, 1067-1071. doi: 10.1038/sj.bjc.6601264.
175. Zhou, G. X., Ireland, J., Rayman, P., Finke, J., and Zhou, M. (2010). Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Urology 75, 257-261. doi: 10.1016/j.urology.2009.09.052.